Targeting Glycosylation Pathways and the Cell Cycle: Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs

Srinivasa Gopalan Sampathkumar, Mark B. Jones, M. Adam Meledeo, Christopher T. Campbell, Sean S Choi, Kaoru Hida, Prasra Gomutputra, Anthony Sheh, Tim Gilmartin, Steven R. Head, Kevin J Yarema

Research output: Contribution to journalArticle

Abstract

Short-chain fatty acid (SCFA)-carbohydrate hybrid molecules that target both histone deacetylation and glycosylation pathways to achieve sugar-dependent activity against cancer cells are described in this article. Specifically, n-butyrate esters of N-acetyl-d-mannosamine (But4ManNAc, 1) induced apoptosis, whereas corresponding N-acetyl-d-glucosamine (But4GlcNAc, 2), d-mannose (But5Man, 3), or glycerol (tributryin, 4) derivatives only provided transient cell cycle arrest. Western blots, reporter gene assays, and cell cycle analysis established that n-butyrate, when delivered to cells via any carbohydrate scaffold, functioned as a histone deacetylase inhibitor (HDACi), upregulated p21WAF1/Cip1 expression, and inhibited proliferation. However, only 1, a compound that primed sialic acid biosynthesis and modulated the expression of a different set of genes compared to 3, ultimately killed the cells. These results demonstrate that the biological activity of butyrate can be tuned by sugars to improve its anticancer properties.

Original languageEnglish (US)
Pages (from-to)1265-1275
Number of pages11
JournalChemistry and Biology
Volume13
Issue number12
DOIs
StatePublished - Dec 2006

Fingerprint

Glycosylation
Butyrates
Prodrugs
Sugars
Cell Cycle
Cells
Carbohydrates
Genes
Neoplasms
Histone Deacetylase Inhibitors
Volatile Fatty Acids
Glucosamine
Biosynthesis
N-Acetylneuraminic Acid
Mannose
Cell Cycle Checkpoints
Bioactivity
Reporter Genes
Scaffolds
Histones

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Targeting Glycosylation Pathways and the Cell Cycle : Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs. / Sampathkumar, Srinivasa Gopalan; Jones, Mark B.; Meledeo, M. Adam; Campbell, Christopher T.; Choi, Sean S; Hida, Kaoru; Gomutputra, Prasra; Sheh, Anthony; Gilmartin, Tim; Head, Steven R.; Yarema, Kevin J.

In: Chemistry and Biology, Vol. 13, No. 12, 12.2006, p. 1265-1275.

Research output: Contribution to journalArticle

Sampathkumar, SG, Jones, MB, Meledeo, MA, Campbell, CT, Choi, SS, Hida, K, Gomutputra, P, Sheh, A, Gilmartin, T, Head, SR & Yarema, KJ 2006, 'Targeting Glycosylation Pathways and the Cell Cycle: Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs', Chemistry and Biology, vol. 13, no. 12, pp. 1265-1275. https://doi.org/10.1016/j.chembiol.2006.09.016
Sampathkumar, Srinivasa Gopalan ; Jones, Mark B. ; Meledeo, M. Adam ; Campbell, Christopher T. ; Choi, Sean S ; Hida, Kaoru ; Gomutputra, Prasra ; Sheh, Anthony ; Gilmartin, Tim ; Head, Steven R. ; Yarema, Kevin J. / Targeting Glycosylation Pathways and the Cell Cycle : Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs. In: Chemistry and Biology. 2006 ; Vol. 13, No. 12. pp. 1265-1275.
@article{c41cbd4c98344b6e8a3435393fd910fb,
title = "Targeting Glycosylation Pathways and the Cell Cycle: Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs",
abstract = "Short-chain fatty acid (SCFA)-carbohydrate hybrid molecules that target both histone deacetylation and glycosylation pathways to achieve sugar-dependent activity against cancer cells are described in this article. Specifically, n-butyrate esters of N-acetyl-d-mannosamine (But4ManNAc, 1) induced apoptosis, whereas corresponding N-acetyl-d-glucosamine (But4GlcNAc, 2), d-mannose (But5Man, 3), or glycerol (tributryin, 4) derivatives only provided transient cell cycle arrest. Western blots, reporter gene assays, and cell cycle analysis established that n-butyrate, when delivered to cells via any carbohydrate scaffold, functioned as a histone deacetylase inhibitor (HDACi), upregulated p21WAF1/Cip1 expression, and inhibited proliferation. However, only 1, a compound that primed sialic acid biosynthesis and modulated the expression of a different set of genes compared to 3, ultimately killed the cells. These results demonstrate that the biological activity of butyrate can be tuned by sugars to improve its anticancer properties.",
author = "Sampathkumar, {Srinivasa Gopalan} and Jones, {Mark B.} and Meledeo, {M. Adam} and Campbell, {Christopher T.} and Sean S Choi and Kaoru Hida and Prasra Gomutputra and Anthony Sheh and Tim Gilmartin and Head, {Steven R.} and Yarema, {Kevin J}",
year = "2006",
month = "12",
doi = "10.1016/j.chembiol.2006.09.016",
language = "English (US)",
volume = "13",
pages = "1265--1275",
journal = "Cell Chemical Biology",
issn = "2451-9448",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Targeting Glycosylation Pathways and the Cell Cycle

T2 - Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs

AU - Sampathkumar, Srinivasa Gopalan

AU - Jones, Mark B.

AU - Meledeo, M. Adam

AU - Campbell, Christopher T.

AU - Choi, Sean S

AU - Hida, Kaoru

AU - Gomutputra, Prasra

AU - Sheh, Anthony

AU - Gilmartin, Tim

AU - Head, Steven R.

AU - Yarema, Kevin J

PY - 2006/12

Y1 - 2006/12

N2 - Short-chain fatty acid (SCFA)-carbohydrate hybrid molecules that target both histone deacetylation and glycosylation pathways to achieve sugar-dependent activity against cancer cells are described in this article. Specifically, n-butyrate esters of N-acetyl-d-mannosamine (But4ManNAc, 1) induced apoptosis, whereas corresponding N-acetyl-d-glucosamine (But4GlcNAc, 2), d-mannose (But5Man, 3), or glycerol (tributryin, 4) derivatives only provided transient cell cycle arrest. Western blots, reporter gene assays, and cell cycle analysis established that n-butyrate, when delivered to cells via any carbohydrate scaffold, functioned as a histone deacetylase inhibitor (HDACi), upregulated p21WAF1/Cip1 expression, and inhibited proliferation. However, only 1, a compound that primed sialic acid biosynthesis and modulated the expression of a different set of genes compared to 3, ultimately killed the cells. These results demonstrate that the biological activity of butyrate can be tuned by sugars to improve its anticancer properties.

AB - Short-chain fatty acid (SCFA)-carbohydrate hybrid molecules that target both histone deacetylation and glycosylation pathways to achieve sugar-dependent activity against cancer cells are described in this article. Specifically, n-butyrate esters of N-acetyl-d-mannosamine (But4ManNAc, 1) induced apoptosis, whereas corresponding N-acetyl-d-glucosamine (But4GlcNAc, 2), d-mannose (But5Man, 3), or glycerol (tributryin, 4) derivatives only provided transient cell cycle arrest. Western blots, reporter gene assays, and cell cycle analysis established that n-butyrate, when delivered to cells via any carbohydrate scaffold, functioned as a histone deacetylase inhibitor (HDACi), upregulated p21WAF1/Cip1 expression, and inhibited proliferation. However, only 1, a compound that primed sialic acid biosynthesis and modulated the expression of a different set of genes compared to 3, ultimately killed the cells. These results demonstrate that the biological activity of butyrate can be tuned by sugars to improve its anticancer properties.

UR - http://www.scopus.com/inward/record.url?scp=33845518649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845518649&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2006.09.016

DO - 10.1016/j.chembiol.2006.09.016

M3 - Article

C2 - 17185222

AN - SCOPUS:33845518649

VL - 13

SP - 1265

EP - 1275

JO - Cell Chemical Biology

JF - Cell Chemical Biology

SN - 2451-9448

IS - 12

ER -